These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26740212)

  • 1. Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival.
    Liu CC; Teh R; Mozar CA; Baxter RC; Rasmussen HH
    Breast Cancer Res Treat; 2016 Jan; 155(2):203-13. PubMed ID: 26740212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacement of Native FXYD Protein From Na
    Liu CC; Kim YJ; Teh R; Garcia A; Hamilton EJ; Cornelius F; Baxter RC; Rasmussen HH
    Front Oncol; 2022; 12():859216. PubMed ID: 35371992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.
    Bibert S; Aebischer D; Desgranges F; Roy S; Schaer D; Kharoubi-Hess S; Horisberger JD; Geering K
    Mol Biol Cell; 2009 Feb; 20(4):1132-40. PubMed ID: 19109419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
    Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
    Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXYD3 (Mat-8), a new regulator of Na,K-ATPase.
    Crambert G; Li C; Claeys D; Geering K
    Mol Biol Cell; 2005 May; 16(5):2363-71. PubMed ID: 15743908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells].
    Qi YY; Liu K; Zhang J; Li K; Ren JJ; Lin P
    Ai Zheng; 2009 Aug; 28(8):861-7. PubMed ID: 19664334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FXYD3 facilitates Na
    Cano Portillo C; Villacreses R; Thurman AL; Pezzulo AA; Zabner J; Thornell IM
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1044-C1051. PubMed ID: 35993520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.
    Bibert S; Liu CC; Figtree GA; Garcia A; Hamilton EJ; Marassi FM; Sweadner KJ; Cornelius F; Geering K; Rasmussen HH
    J Biol Chem; 2011 May; 286(21):18562-72. PubMed ID: 21454534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity.
    McDonald C; Muhlbauer J; Perlmutter G; Taparra K; Phelan SA
    Int J Oncol; 2014 Jul; 45(1):219-26. PubMed ID: 24789097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
    Zhang D; Putti TC
    Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional properties of two human FXYD3 (Mat-8) isoforms.
    Bibert S; Roy S; Schaer D; Felley-Bosco E; Geering K
    J Biol Chem; 2006 Dec; 281(51):39142-51. PubMed ID: 17077088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells.
    Salyer SA; Olberding JR; Distler AA; Lederer ED; Clark BJ; Delamere NA; Khundmiri SJ
    Biochim Biophys Acta; 2013 Oct; 1832(10):1734-43. PubMed ID: 23639630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXYD1 negatively regulates Na(+)/K(+)-ATPase activity in lung alveolar epithelial cells.
    Wujak ŁA; Blume A; Baloğlu E; Wygrecka M; Wygowski J; Herold S; Mayer K; Vadász I; Besuch P; Mairbäurl H; Seeger W; Morty RE
    Respir Physiol Neurobiol; 2016 Jan; 220():54-61. PubMed ID: 26410457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
    Söderlund K; Pérez-Tenorio G; Stål O
    Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.
    Lee SJ; Litan A; Li Z; Graves B; Lindsey S; Barwe SP; Langhans SA
    Mol Cancer; 2015 Aug; 14():159. PubMed ID: 26286140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RNA interference-mediated silencing of toll-like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF-7 and MDA-MB-231 cells: An in vitro study.
    Gao XL; Yang JJ; Wang SJ; Chen Y; Wang B; Cheng EJ; Gong JN; Dong YT; Liu D; Wang XL; Huang YQ; An DD
    J Cell Physiol; 2018 Jan; 234(1):433-442. PubMed ID: 29932226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.
    Okudela K; Yazawa T; Ishii J; Woo T; Mitsui H; Bunai T; Sakaeda M; Shimoyamada H; Sato H; Tajiri M; Ogawa N; Masuda M; Sugimura H; Kitamura H
    Am J Pathol; 2009 Dec; 175(6):2646-56. PubMed ID: 19893046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.